Delivery Order SPE2DB22D1103-SPE2DB25FTEE9
Award Date
1/15/25
Potential Completion Date
2/6/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a period of performance through March 21, 2025 and is a firm fixed-price contract. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,067.35 and a completion date of February 24, 2025. It is a firm fixed-price contract for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $8,067.35, and has an ultimate completion date of January 17, 2025. The contract covers the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,796.30 and is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,061.38 and covers the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication, through March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has a ceiling value of $8,067.35. The contract is a firm-fixed price delivery order with a period of performance through January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. The order, with a ceiling value of $7,792.08, is a firm fixed-price contract that will run through November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,797.84 firm fixed price delivery order is for IBRANCE 75 MG CAPSULE 21S, a medication, with a period of performance through May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, with a ceiling value of $7,797.84, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...